Warner Financial’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Buy |
4,636
+28
| +0.6% | +$2.46K | 0.17% | 82 |
|
|
2025
Q1 | $420K | Hold |
4,608
| – | – | 0.19% | 79 |
|
|
2024
Q4 | $398K | Buy |
4,608
+42
| +0.9% | +$3.63K | 0.17% | 84 |
|
|
2024
Q3 | $434K | Buy |
4,566
+18
| +0.4% | +$1.71K | 0.19% | 85 |
|
|
2024
Q2 | $416K | Buy |
4,548
+27
| +0.6% | +$2.47K | 0.2% | 81 |
|
|
2024
Q1 | $410K | Buy |
4,521
+17
| +0.4% | +$1.54K | 0.21% | 81 |
|
|
2023
Q4 | $367K | Buy |
4,504
+19
| +0.4% | +$1.55K | 0.21% | 78 |
|
|
2023
Q3 | $358K | Buy |
4,485
+22
| +0.5% | +$1.76K | 0.24% | 70 |
|
|
2023
Q2 | $352K | Buy |
4,463
+37
| +0.8% | +$2.92K | 0.23% | 75 |
|
|
2023
Q1 | $344K | Buy |
4,426
+793
| +22% | +$61.6K | 0.24% | 74 |
|
|
2022
Q4 | $282K | Buy |
+3,633
| New | +$282K | 0.21% | 74 |
|